Cite

    Wei Zhang et al.. “Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β‐catenin signaling pathway.” Fundamental & clinical pharmacology, vol. 30, n.d., pp. 596–606. http://access.bl.uk/ark:/81055/vdc_100039060376.0x000037